GSK plc GSK
NYSE GSK
$50.32 -0.09 (-0.18%)
At close: Nov 6, 2026 · 4:00 PM EST

Gsk (GSK) Return on Assets [ROA] (2009 - 2026)

Updated

Gsk (GSK) recorded Return on Assets [ROA] of 19.15% in the quarter ended Sep 30, 2026, up 6.69 percentage points from 12.46% a year earlier but down 2.40 percentage points from the prior quarter.

Analysis

Gsk (GSK) Return on Assets [ROA] (2009 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Gsk reported Return on Assets [ROA] of 10.57%, up 5.53 percentage points from the prior year.

  • Annual Return on Assets [ROA] has a five-year change of +2.91 percentage points (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Return on Assets [ROA] came in at 5.04% in the year ended Dec 31, 2024 (-3.91 pp), 8.94% in the year ended Dec 31, 2023 (-12.62 pp), 21.57% in the year ended Dec 31, 2022 (+15.09 pp) and 6.48% in the year ended Dec 31, 2021 (-1.18 pp).
  • Quarterly Return on Assets [ROA] has ranged from 6.54% in the quarter ended Dec 31, 2024 to 31.72% in the quarter ended Dec 31, 2022 over the past five years.
  • On a year-over-year basis, Return on Assets [ROA] has increased for four consecutive quarters, with an average year-over-year change of +3.76 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 25.10 percentage points in the quarter ended Dec 31, 2022, against a drop of 15.67 percentage points in the quarter ended Dec 31, 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at 21.56% (quarter ended Jun 30, 2026), 24.68% (quarter ended Mar 31, 2026) and 24.44% (quarter ended Dec 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 8.08%
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 7.32%
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 1.87%
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 9.36%
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 9.80%
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -7.67%
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 2.00%
10 Gsk 102.08 Bn 84.92 Bn 8.73 Bn 19.15%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 19.15%
Jun 30, 2026 21.56%
Mar 31, 2026 24.68%
Dec 31, 2025 24.44%
Sep 30, 2025 12.46%
Jun 30, 2025 8.20%
Mar 31, 2025 7.63%
Dec 31, 2024 6.54%
Sep 30, 2024 5.39%
Jun 30, 2024 8.06%
Mar 31, 2024 8.04%
Dec 31, 2023 8.84%
Sep 30, 2023 11.05%
Jun 30, 2023 28.49%
Mar 31, 2023 27.50%
Dec 31, 2022 29.85%
Sep 30, 2022 22.79%
Jun 30, 2022 8.56%
Mar 31, 2022 9.88%
Dec 31, 2021 6.62%
API Access

Gsk Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GSK&period=max&api_key=YOUR_API_KEY